US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

BioNexus Gene Lab Corp

us-stock
To Invest in {{usstockname}}
us-stock
$4.19 0.0115(1.15%) BGLC at 04 Dec 2025 04:26 PM Specialty Chemicals
Lowest Today 4.2
Highest Today 4.4901
Today’s Open 4.3295
Prev. Close 4.35
52 Week High 15.60
52 Week Low 2.01
Day’s Range: Low 4.2 High 4.4901
52-Week Range: Low 2.01 High 15.60
1 day return -
1 Week return -2.22
1 month return -17.13
3 month return -21.28
6 month return +34.55
1 year return +1222.51
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Fundamentals

Market Cap 7.82 M

PB Ratio 1.1966

PE Ratio 0.0

Enterprise Value 5.45 M

Total Assets 10.43 M

Volume 727133

Company Financials

Annual Revenue FY23:10337314 10.3M, FY22:10928707 10.9M, FY21:13362567 13.4M, FY20:11390440 11.4M, FY19:126955 0.1M

Annual Profit FY23:1402169 1.4M, FY22:1259029 1.3M, FY21:2193820 2.2M, FY20:1719823 1.7M, FY19:55888 0.1M

Annual Net worth FY23:-3093429 -3.1M, FY22:-355966 -0.4M, FY21:751571 0.8M, FY20:1094098 1.1M, FY19:-246469 -0.2M

Quarterly Revenue Q3/2025:2543823 2.5M, Q2/2025:2260253 2.3M, Q1/2025:2137075 2.1M, Q3/2024:2630376 2.6M, Q2/2024:1974564 2.0M

Quarterly Profit Q3/2025:377685 0.4M, Q2/2025:368022 0.4M, Q1/2025:343493 0.3M, Q3/2024:326536 0.3M, Q2/2024:288720 0.3M

Quarterly Net worth Q3/2025:-708991 -0.7M, Q2/2025:-616172 -0.6M, Q1/2025:-623327 -0.6M, Q3/2024:-1345370 -1.3M, Q2/2024:199104 0.2M

Fund house & investment objective

Company Information BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Organisation Specialty Chemicals

Employees 30

Industry Specialty Chemicals

CEO Mr. Su-Leng Tan

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right